Annals of Surgical Oncology

, Volume 21, Issue 7, pp 2188–2196 | Cite as

Breast-Conserving Therapy: A Viable Option for Young Women with Early Breast Cancer—Evidence from a Prospective Study

  • Zeming Xie
  • Xi Wang
  • Huanxin Lin
  • Weidong Wei
  • Peng Liu
  • Xiangsheng Xiao
  • Xiaoming Xie
  • Xunhang Guan
  • Mingtian Yang
  • Jun Tang
Breast Oncology



This study evaluated the security of breast-conserving treatment (BCT) in young patients and the effect of regional radiation therapy on young patients with 1–3 positive nodes (N+) treated with BCT.


In this prospective concurrent controlled study, 164 patients were defined as the BCT group, and regional radiation therapy was delivered to patients with 1–3 N+. Modified radical mastectomies (MRMs) were performed on 224 patients without regional radiation therapy.


The 9-year local recurrence (LR) rate of the BCT was 7 %, compared with 3 % in the MRM group (p = 0.055). The 9-year regional recurrence (RR) rate was 6 % for the BCT group and 12 % for the MRM group (p = 0.048). The distant metastasis (DM)-free and breast cancer-specific survival rates were similar between the two groups. RR was an independent prognostic factor for DM [hazard ratio 3.27; 95 % confidence interval (CI) 1.726–6.208] and breast cancer-specific survival (hazard ratio 5.814; 95 % CI 2.690–12.568), whereas LR was not an independent prognostic factor for DM or breast cancer-specific survival.


Young patients treated with BCT have a higher LR rate than that of MRM. However, LR has no detrimental effect on DM-free and breast cancer-specific survival rates, whereas RR is a strong risk factor of DM and death. Regional radiation therapy for young patients with 1–3 N+ may reduce RR and improve survival rates.


Local Recurrence Distant Metastasis Local Recurrence Rate Regional Recurrence Ipsilateral Breast Tumor Recurrence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was supported by the Nature Science Foundation of China (project 81272895), the Natural Science Foundation of Guangdong in China (project S2012040006681), and the Foundation of the Ministry of Science and Technology of Guangdong Province (project 2011B080701052).

Conflict of interest

The authors declare no conflict of interest.


  1. 1.
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Blichert-Toft M, Nielsen M, During M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol. 2008;47:672–81.PubMedCrossRefGoogle Scholar
  4. 4.
    de Bock GH, van der Hage JA, Putter H, Bonnema J, Bartelink H, van de Velde CJ. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer. 2006;42:351–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Baltoyiannis G, Roukos DH, Fatouros M. Increased risk of local recurrence after breast-conserving therapy in young patients. Radiother Oncol. 2008;86:286–7 (author reply 287–8).PubMedCrossRefGoogle Scholar
  6. 6.
    Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer. 2004;101:1302–10.PubMedCrossRefGoogle Scholar
  7. 7.
    Han W, Kim SW, Park IA, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer (abstract). BMC Cancer. 2004;4:82.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Colleen M, Rotmensz N, Robertson C, et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol. 2002;13:273–9.CrossRefGoogle Scholar
  9. 9.
    Arriagada R, Le MG, Contesso G, Guinebretiere JM, Rochard F, Spielmann M. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol. 2002;13:1404–13.PubMedCrossRefGoogle Scholar
  10. 10.
    Kim SI, Park S, Park HS, Kim YB, Suh CO, Park BW. Comparison of treatment outcome between breast-conservation surgery with radiation and total mastectomy without radiation in patients with one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys. 2011;80:1446–52.PubMedCrossRefGoogle Scholar
  11. 11.
    Clavel S, Roy I, Carrier JF, Rousseau P, Fortin MA. Adjuvant regional irradiation after breast-conserving therapy for early stage breast cancer: a survey of Canadian radiation oncologists. Clin Oncol (R Coll Radiol). 2010;22:39–45.PubMedCrossRefGoogle Scholar
  12. 12.
    Wai ES, Lesperance M, Speers CH, et al. Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1-3 positive nodes. Radiother Oncol. 2010;97:301–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Buchholz TA, Woodward WA, Duan Z, et al. Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys. 2008;71:1022–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Olivotto IA, Chua B, Elliott EA, et al. A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial. Clin Breast Cancer. 2003;4:361–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Musat E, Poortmans P, Van den Bogaert W, et al. Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes. Eur J Cancer. 2007;43:718–24.PubMedCrossRefGoogle Scholar
  16. 16.
    Tang J, Wu CC, Xie ZM, Luo RZ, Yang MT. Comparison of clinical features and treatment outcome of breast cancers in young and elderly Chinese patients. Breast Care (Basel). 2011;6:435–40.PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Coulombe G, Tyldesley S, Speers C, et al. Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys. 2007;67:1282–90.PubMedCrossRefGoogle Scholar
  18. 18.
    Touboul E, Buffat L, Belkacemi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:25–38.PubMedCrossRefGoogle Scholar
  19. 19.
    Kim SH, Simkovich-Heerdt A, Tran KN, Maclean B, Borgen PI. Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg. 1998;187:1–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Beadle BM, Woodward WA, Tucker SL, et al. Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys. 2009;73:734–44.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Kroman N, Holtveg H, Wohlfahrt J, et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer. 2004;100:688–93.PubMedCrossRefGoogle Scholar
  22. 22.
    Clark J, Rosenman J, Cance W, Halle J, Graham M. Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 1998;42:345–50.PubMedCrossRefGoogle Scholar
  23. 23.
    Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19:1688–97.PubMedGoogle Scholar
  24. 24.
    Zhou P, Gautam S, Recht A. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2007;101:51–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Truong PT, Vinh-Hung V, Cserni G, Woodward WA, Tai P, Vlastos G. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer. 2008;44:1670–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Fortin A, Dagnault A, Blondeau L, Vu TT, Larochelle M. The impact of the number of excised axillary nodes and of the percentage of involved nodes on regional nodal failure in patients treated by breast-conserving surgery with or without regional irradiation. Int J Radiat Oncol Biol Phys. 2006;65:33–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Li Y, Moran MS, Huo Q, Yang Q, Haffty BG. Post-mastectomy radiotherapy for breast cancer patients with t1-t2 and 1-3 positive lymph nodes: a meta-analysis. PLoS One. 2013;8:e81765.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24:2028–37.PubMedCrossRefGoogle Scholar
  29. 29.
    Anderson SJ, Wapnir I, Dignam JJ, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27:2466–73.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Botteri E, Bagnardi V, Rotmensz N, et al. Analysis of local and regional recurrences in breast cancer after conservative surgery. Ann Oncol. 2010;21:723–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114:403–12.PubMedCrossRefGoogle Scholar
  32. 32.
    Fortin A, Dagnault A, Larochelle M, Vu TT. Impact of locoregional radiotherapy in node-positive patients treated by breast-conservative treatment. Int J Radiat Oncol Biol Phys. 2003;56:1013–22.PubMedCrossRefGoogle Scholar
  33. 33.
    Truong PT, Jones SO, Kader HA, et al. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:357–64.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2014

Authors and Affiliations

  • Zeming Xie
    • 1
    • 2
  • Xi Wang
    • 1
    • 2
  • Huanxin Lin
    • 1
    • 3
  • Weidong Wei
    • 1
    • 2
  • Peng Liu
    • 1
    • 2
  • Xiangsheng Xiao
    • 1
    • 2
  • Xiaoming Xie
    • 1
    • 2
  • Xunhang Guan
    • 1
    • 3
  • Mingtian Yang
    • 1
    • 2
  • Jun Tang
    • 1
    • 2
  1. 1.State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer CenterGuangzhouChina
  2. 2.Departments of Breast OncologySun Yat-sen University Cancer CenterGuangzhouChina
  3. 3.Departments of Radiation OncologySun Yat-sen University Cancer CenterGuangzhouChina

Personalised recommendations